Background: Traditional Chinese medicine (CM) appears to be used worldwide, especially by cancer patients. The aim of the present study was
Introduction
Colorectal cancer (CRC) is one of the most frequently diagnosed cancers and a leading cause of cancer deaths worldwide. The incidence of CRC is increasing and remains the leading cause of death from cancer in Taiwan. The incidence of CRC after age adjustment was 19.6 cases per one hundred thousand people in Taiwan in 2009 (Huang et al., 2012) . Conventional cancer treatments with chemotherapy and radiation therapy have been shown to be effective in reducing or eradicating cancers; however, they can produce unpleasant side effects. Traditional Chinese medicine (CM) is increasingly used as an adjunctive treatment option for cancer patients as a way to reduce or manage the side effects of conventional cancer treatment (Dundee et al.,1989; Liu et al.,1995; Wu et al.,1994) . However, little information exists regarding prevalence, patterns, and costs of CM use among colorectal cancer patients.
CM is one of the most popular complementary and alternative medicine (CAM) modalities. According to an estimation by the World Health Organization, the use of complementary and alternative medicine (CAM) ranges from 9 to 65% in different countries (Ernst,1999 Millar.1997). The utilization of CAM appears to be widespread worldwide, especially among oncology patient (Molassiotis et al., 2005) . Most clinical studies showed that CAM intervention focused on symptom management, in particular, on the management of chemotherapy induced nausea and vomiting (Aglietti et al., 1990; Shen et al., 2000) . However, the contributing factors which push oncology patients to seeking CAM were not well studied yet.
National Health insurance (NHI) was implemented in Taiwan in 1995, and covers more than 99% of Taiwan's 23-million population and 93% of medical institutes. The NHI research Database (NHIRD) provides all registration data sets and claim data sets for research. The NHIRD covered both Western medicine (WM) and CM except claims of CM inpatient services were not included as NHI did not cover it.
In this study, we used NHIRD to explore prevalence, patterns, and cost of insurance-covered CM among colorectal cancer patients. Use of Western medicine (WM) was also surveyed for comparison.
Materials and methods

Data Source
A retrospective cross-sectional study was conducted using registration and claims data sets 
Variables
The modified health service model of Anderson and Newman was used for analysis. Anderson and Newman's model of health service utilization views an individual's use of health service as a function of predisposing, enabling factors and need factor. Predisposing factors included age and gender：age was stratified by two groups, younger than 65, and older than 65. Gender was male and female. Enabling factors included four geographic regions (northern, central, southern and eastern) and three levels of urbanization (urban, suburban and rural) (Engstrom et al.,2001 ). This study also used enrollee category (EC) as a proxy measure of socioeconomic status (Chen et al.,2007) . Need factors were comorbidities (hypertension, diabetes and hyperlipidemia). The dependent variables were factors associated whether or not to use CM. The prevalence, patterns, and cost of insurance-covered by CM users and CM non-users of colorectal cancer patients was analysis.
Statistics
The statistical software packages SAS (version 9.2; SAS Institute, Inc., Cary, NC, USA) and SPSS (version 17; SPSS Inc., Chicago, IL, USA) were used for data analysis. The distribution and frequency of each variable were assessed with chi-square tests. Binary logistic regression was used to estimate the odds ratio (OR) as the measure of association with CM use. P<0.05 was defined as statistically significant.
Results
User demographics
The demographics are presented in Table 1 . The mean age was 67.1 years old. The proportion of older patients was higher than that <65 (61.1% vs. 38.9%). The proportion of male and female patients was 54.6% and 45.4%, respectively. With regard to geographic region, the most proportion registered in Northern and the less proportion in Eastern. The proportion of patients living in suburban with CM users and CM non-users was higher than urban or rural areas. In terms of enrollee category, the proportion of patients in EC 4 among colorectal cancer patients was higher than that the others. was for private clinics. Table 2 revealed the details of visits. Younger survivors (aged < 65 years at diagnosis) were more likely to seek information from sources other than their physicians and to use many different sources for that information, when compared to older survivors (Lawsin et al., 2007) . Information seekers were 5.9 times more likely to use CAM than those who did not seek cancer information (Bennett et al.,2009 ). Females usually took more time to care about their health than did males when they faced the disease at the same time (Lawsin et al., 2007) . In Taiwan, Chinese medicine hospitals were better known in the central southern and eastern regions than in the north. Patients in those regions preferred to see CM doctors because their culture was different from that in the northern region. There are many Western medicine hospitals in the north, and patients there have more choices for care. Patients younger than 65, with higher income, and employed by the government, schools, enterprises or institutions were more likely to be CM users (Huang et al., 2012) . We also found a higher portion of CM users in regions other than Northern Taiwan. This was consistent with previous studies. Nearly two-thirds of the participants did not tell their physicians about using CM. Over two-thirds of all participants (68.2%) believed that integrated CM and WM was effective (Lam et al., 2009 ). Given the high prevalence of CAM use by cancer patients, more research is needed to determine the impact of CAM's effectiveness and safety and its interaction with conventional cancer treatments.
Several limitations of this study should be mentioned. The NHIRD is used primarily for administrative purposes and does not provide data on clinical characteristics such as staging, disease severity, and biochemical data; consequently, these data were not available for analysis in this study. Out-of-pocket and non-contracted clinics were not included. Some cancer patients needed rare and expensive Chinese herbal medicines which were not covered in NHIRD; therefore, the use of CM might have been underestimated.
In conclusion, we found that CM user preferred private hospitals for cancer-specific CM visit and preferred private clinics for non-cancer-specific CM visits. The average costs of CM drugs in CM users were less than in western medicine and CM non-users. Female patients, younger age, and patients not living in the northern region, with higher EC or more comorbidities were more likely to receive CM treatment. Further longer longitudinal study is needed to follow up this trend.
